Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
102.12
-2.45 (-2.34%)
At close: Sep 5, 2025, 4:00 PM
95.34
-6.78 (-6.64%)
After-hours: Sep 5, 2025, 7:59 PM EDT
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $6.78 billion as of September 5, 2025. Its market cap has increased by 143.26% in one year.
Market Cap
6.78B
Enterprise Value
6.61B
1-Year Change
143.26%
Ranking
Category
Stock Price
$102.12
Market Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $786.80M to $6.78B, an increase of 762.08%. That is a compound annual growth rate of 31.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 6.78B | 97.15% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.08% |
| Dec 31, 2021 | 501.68M | -61.83% |
| Dec 31, 2020 | 1.31B | 30.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |